Hemanth Kumar Lakhanapuram
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hemanth Kumar Lakhanapuram has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aliakbar Harudeen
Walailak University, Nakhon Si Thammarat, Thailand
1 shared publication - Gorawit Yusakul
Department of Pharmaceutical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand
1 shared publication - Maria de Lourdes Pereira
University of Porto Rua Dr. Roberto Frias
1 shared publication - Phirabhat Saengsawang
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, 50 Ngamwongwan Road, Bangkok 10900, Thailand
1 shared publication - Tanakamol Mahawan
Akkhraratchakumari Veterinary College, Walailak University, Nakhon Si Thammarat 80160, Thailand
1 shared publication - Veeranoot Nissapatorn
Walailak University, Nakhon Si Thammarat, Thailand
1 shared publication
Latest Publications
- Open Access
- 5 September 2026
- Published by Springer Nature in Journal of Umm Al-Qura University for Applied Sciences
- p. 1-25
Curcuma longa nano-emulsions against bovine mastitis inducing bacteria: Machine-learning based optimization and characterization
This study examined the physicochemical characteristics, antibacterial activity, and anti-biofilm efficacy of Curcuma longa nano-emulsions formulated using a lactic acid–menthol–based hydrophobic deep eutectic solvent as the oil phase and Tween 80–propylene glycol or Tween 20–propylene glycol (1:1, v/v) as surfactant systems, designated C. longa -T-80-8 and C. longa -T-20-8, was evaluated. Droplet size, PDI, and zeta potential were determined for both formulations, and their morphological characteristics were analysed using SEM. The C. longa -T-80-8 formulation demonstrated superior physicochemical performance, exhibiting a smaller droplet size (235.2 ± 6.4 nm), lower PDI (0.219 ± 0.008), and greater electrostatic stability (− 36.6 ± 3.7 mV). Antibacterial assays revealed strong inhibitory activity against Staphylococcus aureus (0.1–0.3 / 0.1–0.6% v/v), Staphylococcus haemolyticus (0.1–0.6 / 0.3–1.25% v/v), and Staphylococcus chromogenes (0.1–1.25 / 0.3–2.5% v/v) isolated from bovine mastitis, with C. longa -T-80-8 exhibiting consistently lower MIC and MBC values. Both nano-emulsions significantly inhibited biofilm formation and effectively eradicated established biofilms. At 32× MIC, C. longa-T-80-8 achieved up to 92.2%, 90.9%, and 90.5% reduction in mature biofilms of S. aureus , S. haemolyticus , and S. chromogenes , respectively. A significant negative correlation between MIC values and biofilm inhibition/eradication indicated a close association between antibacterial potency and antibiofilm efficacy. Furthermore, Random Forest–based machine-learning models provided data-driven validation of the experimental findings, demonstrating predictive performance for growth inhibition, biofilm formation, and bacterial viability, and identifying dose and formulation type as the primary determinants of antimicrobial efficacy. Overall, the Tween 80-based nano-emulsion exhibited superior stability and biological activity, highlighting its potential as a natural alternative to conventional antibiotics for bovine mastitis management. However, the underlying mechanisms of antimicrobial action were not directly investigated in this study and require further validation.
- 5 September 2026
- Published by Springer Nature in Journal of Umm Al-Qura University for Applied Sciences
- p. 1-25
Open AccessCurcuma longa nano-emulsions against bovine mastitis inducing bacteria: Machine-learning based optimization and characterization
This study examined the physicochemical characteristics, antibacterial activity, and anti-biofilm efficacy of Curcuma longa nano-emulsions formulated using a lactic acid–menthol–based hydrophobic deep eutectic solvent as the oil phase and Tween 80–propylene glycol or Tween 20–propylene glycol (1:1, v/v) as surfactant systems, designated C. longa -T-80-8 and C. longa -T-20-8, was evaluated. Droplet size, PDI, and zeta potential were determined for both formulations, and their morphological characteristics were analysed using SEM. The C. longa -T-80-8 formulation demonstrated superior physicochemical performance, exhibiting a smaller droplet size (235.2 ± 6.4 nm), lower PDI (0.219 ± 0.008), and greater electrostatic stability (− 36.6 ± 3.7 mV). Antibacterial assays revealed strong inhibitory activity against Staphylococcus aureus (0.1–0.3 / 0.1–0.6% v/v), Staphylococcus haemolyticus (0.1–0.6 / 0.3–1.25% v/v), and Staphylococcus chromogenes (0.1–1.25 / 0.3–2.5% v/v) isolated from bovine mastitis, with C. longa -T-80-8 exhibiting consistently lower MIC and MBC values. Both nano-emulsions significantly inhibited biofilm formation and effectively eradicated established biofilms. At 32× MIC, C. longa-T-80-8 achieved up to 92.2%, 90.9%, and 90.5% reduction in mature biofilms of S. aureus , S. haemolyticus , and S. chromogenes , respectively. A significant negative correlation between MIC values and biofilm inhibition/eradication indicated a close association between antibacterial potency and antibiofilm efficacy. Furthermore, Random Forest–based machine-learning models provided data-driven validation of the experimental findings, demonstrating predictive performance for growth inhibition, biofilm formation, and bacterial viability, and identifying dose and formulation type as the primary determinants of antimicrobial efficacy. Overall, the Tween 80-based nano-emulsion exhibited superior stability and biological activity, highlighting its potential as a natural alternative to conventional antibiotics for bovine mastitis management. However, the underlying mechanisms of antimicrobial action were not directly investigated in this study and require further validation.